Genetic variants in purine metabolism and treatment resistance in schizophrenia: evidence supporting the adenosine hypothesis - a pilot study.

Pjevac M, Blagus T, Oblak A, Vogrinc D, Terzić T, Bon J, Dolžan V

Open source

DOI
10.3389/fphar.2026.1876365
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1876365,
  title = {Genetic variants in purine metabolism and treatment resistance in schizophrenia: evidence supporting the adenosine hypothesis - a pilot study.},
  author = {Pjevac M and Blagus T and Oblak A and Vogrinc D and Terzić T and Bon J and Dolžan V},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1876365},
  url = {https://doi.org/10.3389/fphar.2026.1876365}
}

RIS

TY  - JOUR
TI  - Genetic variants in purine metabolism and treatment resistance in schizophrenia: evidence supporting the adenosine hypothesis - a pilot study.
AU  - Pjevac M
AU  - Blagus T
AU  - Oblak A
AU  - Vogrinc D
AU  - Terzić T
AU  - Bon J
AU  - Dolžan V
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1876365
UR  - https://doi.org/10.3389/fphar.2026.1876365
ER  - 

APA

M, P., T, B., A, O., D, V., T, T., J, B., & V, D. (2026). Genetic variants in purine metabolism and treatment resistance in schizophrenia: evidence supporting the adenosine hypothesis - a pilot study.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1876365

Source records